The health care team at Marshall University and Cabell Huntington recently published a case report in the Journal of Pediatric Health Care regarding withdrawal symptoms of a neonate exposed to a fentanyl analog in utero. The researchers highlight the complex medical and social issues involved with treating infants with Neonatal Abstinence Syndrome that were exposed to many substances.
Read Journal Article Here:
Novel Withdrawal Symptoms of a Neonate Prenatally Exposed to a Fentanyl Analog
Related Resources
Recent news
Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome
May 5, 2020Free Livestream Educational Webinar on Neonatal Abstinence Syndrome
May 1, 2020Opioid Crisis In Medicaid: Saving Mothers And Babies
April 8, 2020Preparing your maternal and neonatal units to respond to COVID-19
March 23, 2020Contact
Amy Tolliver, Director
West Virginia Perinatal Partnership
(304) 558-0530 ext. 5
atolliver@wvperinatal.org
Share this Post